Skip to main content

1st AndroGel Trial: Plaintiffs Allowed to Present All Claims

1st AndroGel Trial: Plaintiffs Allowed to Present All Claims

1st AndroGel Trial: Plaintiffs Allowed to Present All Claims

Introduction

Retrial for a previously tossed $150 million AndroGel verdict announced as punitive damages and no compensatory damages in favor of the plaintiff began on March 7. The plaintiff was allowed to present all claims to the jury by the U.S. District Judge Matthew Kennelly presiding over the centralized testosterone replacement therapy lawsuits in the Northern District of Illinois. The plaintiff was earlier ordered by the court that the jury would only reconsider the issue of fraudulent misrepresentation. The court vacated the prior judgment in its entirety and ordered a new trial on all claims.

Other defendants named in the testosterone litigation namely Eli Lilly, Auxilium Pharmaceuticals, Endo Pharmaceuticals, and GlaxoSmithKline have opted to settle the lawsuits against them. However, no signs of settlements are seen from AbbVie and the company faces nearly 4,510 cases nationally over injuries blamed on AndroGel.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.